Production (Stage)
Cardlytics, Inc.
CDLX
$1.84
-$0.05-2.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.35% | 10.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.35% | 10.35% | |||
| Cost of Revenue | -10.97% | 7.17% | |||
| Gross Profit | -23.14% | 14.64% | |||
| SG&A Expenses | 5.65% | -0.50% | |||
| Depreciation & Amortization | 5.91% | -14.78% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.15% | -2.02% | |||
| Operating Income | -135.78% | 51.25% | |||
| Income Before Tax | 14.80% | 89.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.80% | 89.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.80% | 89.26% | |||
| EBIT | -135.78% | 51.25% | |||
| EBITDA | -474.86% | 76.98% | |||
| EPS Basic | 16.20% | 89.47% | |||
| Normalized Basic EPS | -17.91% | -12.64% | |||
| EPS Diluted | 14.92% | 89.47% | |||
| Normalized Diluted EPS | -17.91% | -12.64% | |||
| Average Basic Shares Outstanding | 1.68% | 1.95% | |||
| Average Diluted Shares Outstanding | 1.68% | 1.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||